Advanced search
Publication Cover
Hospital Practice Volume 50, 2022 - Issue 2
Submit an article Journal homepage
151
Views
3
CrossRef citations to date
0
Altmetric
Clinical feature - Original research

Evaluation of aerosolized epoprostenol for hypoxemia in non-intubated patients with coronavirus disease 2019

Vivek Katariaa Department of Pharmacy, Baylor University Medical Center, Dallas, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1149-5937
ORCID Icon,
Klayton Rymana Department of Pharmacy, Baylor University Medical Center, Dallas, TX, USA
,
Ginger Tsai-Nguyenb Department of Critical Care-Medical Intensive Care Unit, Baylor University Medical Center, Dallas, TX, USA
,
Yosafe Wakwayab Department of Critical Care-Medical Intensive Care Unit, Baylor University Medical Center, Dallas, TX, USA
&
Ariel Modrykamienb Department of Critical Care-Medical Intensive Care Unit, Baylor University Medical Center, Dallas, TX, USA
Pages 118-123 | Received 01 Oct 2021, Accepted 16 Feb 2022, Published online: 10 Mar 2022

References

  • Wunsch H. Mechanical ventilation in COVID-19: interpreting the current epidemiology. Am J Respir Crit Care Med. 2020;202(1):1–21.
  • Ranney M, Griffeth V, Jha A. Critical supply shortage- the need for ventilators and personal protective equipment during the covid-19 pandemic. N Engl J Med. 2020;382(18):e41.
  • COVID-19 treatment guidelines panel. coronavirus disease 2019 (COVID-19) treatment guidelines. Retrieved 10 October 2021. National Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov/critical-care/
  • Waleed A, Laura E, Fayez A, et al. Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update. Crit Care Med. 2021;49(3):e219–e234.
  • The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384(8): 693–704.
  • The RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637–1645.
  • REMAP-CAP Investigators. Interleukin-6 receptor antagonists in critically Ill patients with COVID-19. N Engl J Med. 2021;384(16):1491–1502. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa2100433
  • Flolan (epoprostenol sodium) [package insert]. Triangle Pack (NC): GlaxoSmithKline; 2015.
  • Searcy RJ, Morales JR, Ferreira JA, et al. The role of inhaled prostacyclin in treating acute respiratory distress syndrome. Ther Adv Respir Dis. 2015;9(6):302–312.
  • Fuller BM, Mohr NM, Skrupky L, et al. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest. 2015;147(6):1510–1522.
  • Li J, Gurnani PK, Roberts KM, et al. The clinical impact of flow titration on epoprostenol delivery via high flow nasal cannula for ICU patients with pulmonary hypertension or right ventricular dysfunction: a retrospective cohort comparison study. J Clin Med. 2020;9(2):464.
  • Li J, Harnois LJ, Markos B, et al. Epoprostenol delivered via high flow nasal cannula for ICU subjects with severe hypoxemia comorbid with pulmonary hypertension or right heart dysfunction. Pharmaceutics. 2019;11(6):281.
  • Ammar MA, Sasidhar M, Lam SW. Inhaled epoprostenol through noninvasive routes of ventilator support systems. Ann Pharmacother. 2018;52(12):1173–1181.
  • Dondorp A, Hayat M, Aryal D, et al. Schultz M. respiratory support in COVID-19 patients, with a focus on resource-limited settings. Am J Trop Med Hyg. 2020;102(6):1191–1197.
  • Ehrmann S, Li J, Ibarra-Estrada M, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomized, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9(12):1387–1395.
  • The National Heart. Lung, and blood institute acute respiratory distress syndrome (ards) clinical trials network. comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24): 2564–2575.
  • Collins JA, Rudenski A, Gibson J, et al. Relating oxygen partial pressure, saturation, and content: the haemoglobin-oxygen dissociation curve. Breathe. 2015;11(3):194–201.
  • Sonti R, Pike W, Cobb N. Responsiveness of inhaled epoprostenol in respiratory failure due to COVID-19. J Intensive Care Med. 2020;36(3):327–333.
  • Li J, Gong L, Fink J. The ratio of nasal cannula gas flow to patient inspiratory flow on trans-nasal pulmonary aerosol delivery for adults: an in vitro study. Pharmaceutics. 2019;11(5):225.
  • Li J, Fink J, MacLoughlin R, et al. Review on trans-nasal pulmonary aerosol delivery. Crit Care. 2020;24:506.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.